Schedule

Thursday, August 9th

1:00 PM	Registration
2:00 PM	Opening Remarks
2:10 PM	David Drewry (GSK)	Design and Synthesis of Kinase Inhibitors
3:00 PM	Discussion
3:20 PM	Kamil Paruch (Schering Plough)	Discovery of Novel CDK Inhibitors
4:10 PM	Discussion
4:30 PM	Break
4:50 PM	Mark Mascal (U. of California, Davis)	Hemifullerenes of C(20-n)N(n) and Ion Sandwiches
5:40 PM	Discussion
6:00 PM	Cocktail Hour

Friday, August 10th

8:30 AM	Normand Hebért (SGX Pharmaceuticals)	FASTT Fragment-Based Discovery of Hepatitis C Virus NS5b RNA Polymerase Inhibitors
9:20 AM	Discussion
9:35 AM	Break
9:50 AM	Tom Bell (U. of Nevada, Reno)	Synthesis and QSAR Studies of CD4 Down-Modulating 1,5,9-Triazacyclododecanes
10:40 AM	Discussion
10:55 AM	Justin Gallivan (Emory U.)	Reprogramming Bacteria with Small Molecules and RNA
11:45 AM	Discussion
12:00 PM	Lunch
2:00 PM	Peter Jacobi (Dartmouth College)	Studies on the Synthesis of Furanosteroids
2:50 PM	Discussion
3:05 PM	George Painter (Chimerix)	A Broad Spectrum Antiviral Agent for the treatment of doubled stranded DNA Viral Infection
3:55 PM	Discussion
4:10 PM	Break
4:30 PM	Kay Brummond (U. of Pittsburgh)	Cyclocarbonylation and Cycloisomerization Reactions of Allenes
5:20 PM	Discussion
6:00 PM	Cocktail Hour

Saturday, August 11

8:30 AM	John Montgomery (U. of Michigan)	Recent Advances in Nickel-Catalyzed Reactions
9:20 AM	Discussion
9:35 AM	Bruce E. Maryanoff (Johnson & Johnson Pharmaceutical R&D)	Structure-Based Drug Design Applied to Serine Protease Inhibitors
10:25 AM	Discussion
10:40 AM	Break
11:00 AM	David Lynn (Emory University)	TBA
11:45 AM	Discussion
12:00 PM	Closing Remarks